Stay updated on AEB1102 in Arginase I Deficiency Clinical Trial
Sign up to get notified when there's something new on the AEB1102 in Arginase I Deficiency Clinical Trial page.

Latest updates to the AEB1102 in Arginase I Deficiency Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe site revision shows Revision: v3.4.2 and removes the prior funding-notice banner, a UI/system update that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check41 days agoChange DetectedAdded a government funding notice about information possibly not being up to date and updated the revision from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check48 days agoChange DetectedAdded 'Show glossary', updated the QC-related label to 'Last Update Submitted that Met QC Criteria', and introduced a 'No FEAR Act Data' note with revision tag 'v3.4.0'. Removed the older QC label 'Last Update Submitted that met QC Criteria' and the older 'No FEAR Act data', updating from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check63 days agoChange DetectedRevision metadata updated: added Revision: v3.3.4 and removed Revision: v3.3.3.SummaryDifference0.1%

- Check84 days agoChange DetectedLocations section added with the listed sites (California, Florida, Michigan, New York, Texas, Washington, Ontario) and the page revision updated to v3.3.3; the old location headings and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.9%

Stay in the know with updates to AEB1102 in Arginase I Deficiency Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AEB1102 in Arginase I Deficiency Clinical Trial page.